:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Fkate-bingham.jpg)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2FKB-Fortune.PNG)
VideoHouman Ashrafian participated in the Female Founders panel ‘Building a diverse leadership team and board’
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fevidation-wordmark-black-cmyk.png)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FSpectrum_Logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Famathus-therapeutics-logo.png){kind=logo}
The Annual Healthcare Growth Update
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FNordic-logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FHPS-Logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAeroCare-logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FBardyDx_Logo_HiRes_RGB.png){kind=logo}
Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fhealthify-logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fribometrix.png)
SV Health Investors Promotes Greg Madden to Managing Partner
Merck KGaA and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FLOGOJPGsCatamaran_rgb.jpg)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCentauri-logo.png){kind=logo}
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2Fkate-bingham.jpg)
12 June 2021SV NewsKate Bingham is recognised in this year's Queen’s Birthday Honours List
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2FDDF-logo.png)
9 June 2021SV NewsThe Dementia Discovery Fund’s Portfolio Company Caraway Therapeutics Establishes Collaboration with AbbVie to develop small molecule therapeutics targeting Parkinson’s disease and other neurodegenerative disorders
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCarawayTx_rgb_large1.png)
9 June 2021Portfolio NewsCaraway Therapeutics Establishes Collaboration with AbbVie to Develop Novel Small Molecule Therapeutics for Parkinson’s Disease and Other Related Disorders- 7 June 2021SV NewsThe Dementia Discovery Fund welcomes FDA’s approval of aducanumab for Alzheimer’s disease
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FTransine-Colour-Logo.jpg)
2 June 2021Portfolio NewsTransine Therapeutics Closes Extended Seed Funding of £9.1 million co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to advance its novel class of therapeutic RNAs
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FQuralisRectangle-logo.png)
26 May 2021Portfolio NewsQurAlis Boosts World-Class Leadership Team With Addition of Three New Members
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Ftherino-bio-logo.png)
10 May 2021Portfolio NewsTherini Bio Secures $17 Million Investment to Advance Fibrin Therapeutic Candidates Towards the Clinic- 5 May 2021SV NewsThe Dementia Discovery Fund Appoints Luca Santarelli, M.D., a Proven Neuroscience Leader, as the New Chair of its Scientific Advisory Board
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCumulus.png)
4 May 2021Portfolio NewsCumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAlchemab-logo.png)
15 April 2021Portfolio NewsAlchemab raises £60M ($82M) in Series A financing to advance novel platform for identifying disease-modifying antibody therapeutics- 7 April 2021SV NewsThe Dementia Discovery Fund Significantly Enhances its Neuroscience R&D Expertise to Support its Portfolio
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Famathus-therapeutics-logo.png)
17 March 2021Portfolio NewsAmathus Therapeutics signs strategic collaboration with Merck to Develop Treatments for Neurodegenerative Diseases